8th Annual Allogeneic Cell Therapies Summit

The 8th Annual Allogeneic Cell Therapies Summit focuses on advancing allogeneic cell therapies by addressing manufacturing challenges, clinical outcomes, and innovative product development.

Key Topics

• Refining processes for scalable and high-quality allogeneic production
• Optimizing patient dosing and treatment for lasting therapeutic outcomes
• Leveraging cell engineering to enhance anti-tumor properties of allogeneic cells
• Using cell engagers to boost activity endogenously and in combination with treatments
• Sharing insights on allogeneic therapies beyond hematologic malignancies
• Addressing bottlenecks to manufacturing larger cell batches for mass production
• Designing allogeneic products to minimize adverse effects of allotransplantation
• Revitalizing progress by managing investor expectations and demonstrating clinical data
• Building commercial success through strategic product development and regulatory expertise
• Laying foundations for seamless transitions to large-scale manufacturing
• Achieving reliable genetic engineering to transform allogeneic cells
• Leveraging automation to reduce costs and errors in the manufacturing process

Who should Attend

• Process development specialists
• Regulatory experts
• Investors in biotechnologies
• Allogeneic therapy researchers
• Pharmaceutical product developers
• Oncology specialists
• Manufacturing professionals in cell therapy
• Clinical data analysts